酿酒酵母(Saccharomyces cerevisiae)半乳糖可诱导表达系统特性的研究

把大肠杆菌β-半乳糖苷酶基因克隆到带有酵母半乳糖可诱导启动子GAL1的穿梭表达质粒pYESZ中,并把得到的重组质粒分别转化到两种不同遗传性状的宿主菌中,其中一株菌为蛋白酶活性缺失90％以上的pep4－3突变菌株。通过比较两株重组菌产生的β-半乳糖苷酶活性水平发现在所述实验条件下,蛋白酶缺失突变菌株中产生的β-卜半乳糖苷酶活水平不仅均要高于另一对照菌株,并且pep4-3突变菌株表现出受葡萄糖阻遏的严紧程度高及对诱导反应迅速等特点。此外,带有重组质粒的pep4－3突变菌株在葡萄糖阻遏培养基中最大生长量和重组对照菌株基本相同,但β-半乳糖苷酶在pep4－3突变菌株中的表达对细胞生长的影响明显小于对照菌株。     

酿酒酵母(Saccharomyces cerevisiae)半乳糖可诱导表达系统特性的研究

把大肠杆菌β一半乳糖苷酶基因克隆到带有酵母半乳糖可诱导启动子GALl的穿梭表达质粒pYES2中,并把得到的重组质粒分别转化到两种不同遗传性状的宿主菌中,其中一株菌为蛋白酶活性缺失90％以上的pep4-3突变菌株。通过比较两株重组菌产生的β一半乳糖苷酶活性水平发现在所述实验条件下,蛋白酶缺失突变菌株中产生的β一半乳糖苷酶活水平不仅均要高于另一对照菌株,并且pep4-3突变菌株表现出受葡萄糖阻遏的严紧程度高及对诱导反应迅速等特点。此外,带有重组质粒的pep4-3突变菌株在葡萄糖阻遏培养基中最大生长量和重组对照菌株基本相同,但β一半乳糖苷酶在pep4-3突变菌株中的表达对细胞生长的影响明显小于对照菌株。     

葡萄糖脱氢酶高产工程菌的构建及融合蛋白的一步纯化

PCR扩增葡萄糖脱氢酶基因(glucose dehydrogenase, gdh),连接到测序载体pUC19,转化大肠杆菌JM109,测序(GenBank登录号:EF626962)后,亚克隆到表达载体,转化大肠杆菌M15,筛选得到GDH高产工程菌M15/pQE31-gdh8.工程菌经IPTG诱导表达,超声波破碎,粗酶液比活力高达15 U/mg.镍凝胶柱亲和层析纯化表达蛋白,超滤、冻干后,比活力达360 U/mg.重组质粒pQE31-gdh8在E .coli M15中稳定程度高达99.8%.工程菌M15/pQE31-gdh8诱导表达的重组酶活力高,易纯化,重组质粒稳定程度高,具有良好的工业应用前景.     

组成型表达粪产碱杆菌青霉素G酰化酶重组大肠杆菌发酵条件研究

目的:对重组大肠杆菌组成型表达粪产碱杆菌青霉素G酰化酶(AfPGA)进行了发酵条件研究。方法:在摇瓶和5L发酵罐中研究了(NH4)2SO4和葡萄糖浓度对质粒的分离稳定性及青霉素G酰化酶表达的影响。结果:该工程菌质粒具有分离不稳定性,培养基中无(NH4)2SO4时发酵过程中pH和糊精水解生成葡萄糖的浓度变化较小,细胞前期(0h-12h)的生长速率降低,质粒分离稳定性和青霉素G酰化酶的表达水平提高。发酵过程中维持低葡萄糖水平可以限制细胞的生长速率,提高质粒稳定性和促进青霉素G酰化酶的合成。采用混合碳源发酵,发酵培养基含糊精2g/L,12h后以1g/L.h恒速流加葡萄糖至35h,控制流加过程葡萄糖浓度0.1g/L左右,平均比生长速率为0.06h-1,发酵结束时质粒稳定性为86%,青霉素G酰化酶的表达水平达23 000U/L。结论:重组大肠杆菌组成型表达青霉素G酰化酶的研究对工业生产有一定指导意义。     

甲基对硫磷水解酶的酿酒酵母表面展示及在甲基对硫磷降解中的应用

PCR扩增假单胞菌WBC-3的甲基对硫磷水解酶基因,插入表面展示质粒pYD1的多克隆位点,构建pYD1-MPH重组质粒。重组质粒转化酿酒酵母EBY100,2%半乳糖诱导甲基对硫磷水解酶表达,并利用免疫荧光检测甲基对硫磷水解酶在酿酒酵母细胞表面的表达展示。研究了表面展示甲基对硫磷水解酶的酶学性质和酵母工程菌对水体中甲基对硫磷的降解效果。结果表明成功构建具有全细胞甲基对硫磷水解酶催化活性的酵母工程菌,经2%半乳糖诱导48 h,表面展示甲基对硫磷水解酶比酶活力为18.2 U/mg细胞干重。表面展示甲基对硫磷水解酶的最适作用pH为9.5,最适作用温度为30℃,在p H4.0-10.5之间和45℃以下稳定性较好,Mn2+、Co2+、Zn2+、Ca2+、Hg2+、K+、Ni2+对表面展示甲基对硫磷水解酶活性有激活作用,Na+、Fe3+、Ag+对展示酶活力有抑制作用。工程菌在1 h内对淡水中20 mg/L的甲基对硫磷的降解率在80%以上。     

酿酒酵母（Saccharomyces cerevisiae）半乳糖可诱导表达系统特性的研究

把大肠杆菌β－半乳糖苷酶基因克隆到带有酵母半乳糖可诱导启动子ＧＡＬ１的穿梭表达质粒ｐＹＥＳ２中,并把得以的重组质粒分别转化到两种不同遗传性状的宿主菌中,其中一株菌为蛋白酶活性缺失９０％以上的ｐｅｐ４－３突变菌株。通过比较两株重组菌产生的β－半乳糖苷酶活性水平发现在所述实验条件下,蛋白酶缺失突变菌株中产生的β－半乳糖苷酶少水平不仅均要高于另一对照菌株,并且ｐｅｐ４－３突变菌株表现受葡萄糖阻遏的严紧程     

重组葡激酶工程菌的构建方法

目的：利用N端缺失10个氨基酸的葡激酶（recombinant staphylokinase,rSaK）重组质粒,构建了表达可溶性rSaK126蛋白的工程菌,并研究不同条件下工程菌诱导表达目的蛋白含量的差异及纯化途径。 方法：采用细菌活化和培养方法诱导目的蛋白,并用SDS-PAGE测其含量,应用层析技术纯化蛋白。 结果：成功构建表达重组葡激酶的工程菌,表达的重组葡激酶蛋白约占菌体总蛋白的50％,经纯化后回收率为60%,纯度达99%以上。结论：成功构建高效表达重组葡激酶的工程菌,并获得了高含量、高纯度的目的蛋白。     

GL-7ACA酰化酶基因工程菌(Escherichia coli MMR204/pZC1)批式补糖发酵条件优化

戊二酰-7-氨基头孢烷酸(GL-7-ACA)酰化酶(3．1．5．11)可有效催化GL-7ACA分子中戊二酰基侧链水解,形成7-氨基头孢烷酸(7-ACA)而成为两步酶法生产7-ACA的重要工业用酶之一。在已构建的GL-7ACA酰化酶基因(acy)重组质粒pZC1基础上,进一步对酰化酶基因工程菌Escherichia coli MMR204／pZC1的产酶发酵条件进行了考察。研究表明,工程菌的最佳发酵温度为33℃,pH7．5～8．5的微碱条件有利于酶的生成。LB培养基补加适量葡萄糖(1～5g／L),可提高发酵生物量和产酶水平,但葡萄糖的过量补加(6g／L以上),则导致发酵液偏酸(低至pH4．0)而完全抑制酰化酶生成,并证明工程菌生长和产酶对乙酸的抑制效应较为敏感。同时通过5L自控发酵罐的批式补糖试验,对恒速流加、pH反馈控制和指数流加等三种补糖模式的发酵产酶进程进行了比较。结果发现,三种方式的补糖条件下,acy基因在tac启动子控制下,呈组成型表达,细胞生长与产酶同步,无需诱导;其中,以指数流加方式得到的生物量和产酶水平最高。而从acy基因的表达效率,即比酶活看,pH反馈的补料方法略高于恒速或指数流加模式。     

抗菌肽Adenoregulin基因工程菌培养条件的优化及分批发酵研究

denoregulin（ADR）是来源于南美树蛙Phyllomedusa bicolor皮肤的含有33个氨基酸的抗菌肽,在非极性环境中形成α_螺旋型结构,具有抗菌活性强、抗菌谱广的特点。将ADR基因克隆于pET32a载体上,转化大肠杆菌BL21(DE3),对这一工程菌株的培养条件进行了优化。通过正交试验,考察诱导时机、诱导剂量和诱导时间三个因素的不同水平对蛋白表达的影响,结果发现诱导时机的影响尤为显著,考察了9种不同培养基对表达量的影响,发现培养基中加入葡萄糖对目标蛋白的稳定表达起了重要的作用,确定最佳培养条件为：培养基为2×YT+0.5%葡萄糖,诱导时机为OD600=0.9左右,诱导剂IPTG加入的终浓度为0.1mmol/L,诱导时间为4h。采用前期恒pH、后期指数流加的策略进行工程菌BL21(DE3)/pET32a-adr的高密度培养,在整个流加过程中,通过控制葡萄糖的加入量,将菌株的比生长速率控制在015h^-1,乙酸浓度也被控制在较低的水平(<2g/L),但是质粒丢失严重,在发酵结束时,约有40%的大肠杆菌中不带质粒,这导致了目标蛋白的表达量下降严重,但是表达的目标蛋白90%以上为可溶性形式。表达的融合蛋白无抑菌活性,而裂解后得到的ADR单体具有明显的抑菌活性。     

FAD依赖的葡萄糖脱氢酶多拷贝毕赤酵母菌株的构建及高效表达

通过体外多拷贝构建实现FAD依赖的葡萄糖脱氢酶(FAD-GDH)在毕赤酵母(Pichia pastoris)X33菌株中的高效表达。将前期构建的经密码子偏好性优化FAD-GDH基因插入到pPICZαA质粒中，通过同尾酶法酶切酶连构建含1～4个表达盒的重组表达质粒，分别电转至毕赤酵母X33中，成功筛选到各种重组菌株。qRT-PCR测定结果表明，载体所含的表达盒数目与嵌合进毕赤酵母基因组中的GDH基因拷贝数之间存在正相关关系。重组菌在试管水平用甲醇诱导72 h,酶活达到最高，其中4拷贝的转化子表达水平最高；选择1拷贝和4拷贝转化子进行10 L发酵罐扩大培养，1拷贝菌株诱导108 h酶活达到最高697.125 U/mL,4拷贝菌株诱导132 h酶活达到最高1 063.279 U/mL,比1拷贝酶活提高52.52%。结果表明通过增加目的基因拷贝数策略有助于提高FAD-GDH的表达量，为其进一步扩大生产提供参考。     

Differential medium for selection of bacterial L-asparaginase producer strains

A specific, fast, and easy method for revelation of active plate producers of L-asparaginase using differential medium on the basis of LB or M9 with 1.5% agar was developed. Each 100 ml of LB or M9 medium additionally contained 6-7 ml ofglycerol, 4 g of L-asparagine, 0.2 g of CaCO3, and diagnostic components: 3 ml of 0.2 M CuSO4 x 5H2O and 2.5 ml of 0.1 M K3Fe(CN)6, pH 7.6-7.8. The results were counted 12-20 or 24-48 h after strain growth at 37 degrees C in corresponding mediums. Red color of colonies and colored zone around them showed the ability of the strain under study to destroy asparaginic complexes. The recommended method allows revealing bacterial strains producing L-asparaginase with specific activity of not less than 0.1-3.0 MU/mg of protein.     

Differential medium for revelation of bacterial producer strains of L-asparaginases

A specific, fast, and easy method for revelation of active plate producers of L-asparaginase using differential medium on the basis of LB or M9 with 1.5% agar was developed. Each 100 ml of LB or M9 medium additionally contained 6–7 ml of glycerol, 4 g of L-asparagine, 0.2 g of CaCO₃, and diagnostic components: 3 ml of 0.2 M CuSO₄ · 5H₂O and 2.5 ml of 0.1 M K₃Fe(CN)₆, pH 7.6–7.8. The results were counted 12–20 or 24–48 h after strain growth at 37°C in corresponding mediums. Red color of colonies and colored zone around them showed the ability of the strain under study to destroy asparaginic complexes. The recommended method allows revealing bacterial strains producing L-asparaginase with specific activity of not less than 0.1–3.0 MU/mg of protein.     

人溶菌酶工程菌株培养条件的研究

人溶菌酶在食品工业和医药上具有广泛的用途,最近发现它在癌症的继承性免疫治疗上也有作用。为使人溶菌酶达到工业化生产,我们已成功地人工合成厂人溶菌酶基因,并构建了人溶菌酶基因的重组质粒和工程菌株。为提高该工程菌人溶菌酶的表达水平,我们对影响该工程菌表达人溶菌酶的培养条件进行探讨。     

THE OPTIMUM PH OF FOUR STRAINS OF ACIDOPHILIC SNOW ALGAE IN THE GENUS CHLOROMONAS (CHLOROPHYTA) AND POSSIBLE EFFECTS OF ACID PRECIPITATION1

Four axenic strains of snow algae were examined for optimum pH under laboratory conditions using M-1 growth medium. Growth was measured using cell counts, cell measurements and absorbance readings at 440 nm. Strains C204 and C479A of Chloromonas sp. from the Adirondack Mountains, New York, grew optimally at pH 4.0 to 5.0. Strains C381F and C381G, Chloromonas polyptera (Fritsch) Hoh., Mull. & Roem. from the White Mountains, Arizona, grew optimally at pH 4.5 to 5.0. Growth was significantly higher at pH 4.0 in the northeastern species (Chloromonas sp.), but no significant difference was observed in final growth at pH 4.5, 5.0 and 5.5 between species. It is postulated that the more acidic precipitation in the northeastern United States may be selecting for strains of snow algae with greater tolerance to acidity than in strains from the southwestern United States or that the different pH optima reported are simply species differences. New York strain C204 was also grown in heavily buffered AM medium where it had an optimum pH of 5.0, but cells became irregularly shaped and tended to clump at pH 6.0 to 7.0. Growth of C204 in AM medium was significantly lower than in M-1 medium for snow algae. These findings justify the use of M-1 medium for this type of experimentation.     

L-asparaginase produced from soil isolates of Pseudomonas aeruginosa shows potent anti-cancer activity on HeLa cells

Among cancers, acute lymphoblastic leukemia (ALL) occurs in the children <15 years of age. L-asparaginase is an important therapeutic enzyme used for treating ALL. Owing to its therapeutic use and demand, microorganisms have been in use for many years to produce L-asparaginase on an industrial scale. Gram-negative bacteria (Serratia, Erwinia and Escherichia coli) species were used in L-asparaginase. However, earlier studies have documented that the long-term use of enzymes produced from these commercial strains induces hypersensitivity in patients. Therefore, there is a need to discover novel microbial strains producing L-asparaginase with anti-cancer properties, which can be employed for the commercial production of the enzyme. In this study, three strains of Pseudomonas aeruginosa (accession numbers LC425424 (P31), LC425425 (P32), and LC425426 (P34)) isolated from garden soil were screened for the invention of L-asparaginase. Fermented production media was dialyzed to attain the purified enzyme, thus showed a dose-depended cytotoxic effect on HeLa cells, as determined by MTT assay. The IC₅₀s of the different isolates were 86.73, 57.65, and 40.34 µg/mL. These results indicate that pseudomonal L-asparaginase may be used for cancer treatment.     

嗜水气单胞菌TPS-30株丝氨酸蛋白酶基因与溶血素基因在大肠杆菌中的融合表达

嗜水气单胞菌丝氨酸蛋白酶和溶血素是该菌重要的致病因子与保护性抗原。致病性嗜水气单胞菌TPS-30株为江浙一带鱼类暴发病病原主要血清型O:9的代表株。研究利用PCR方法扩增嗜水气单胞菌TPS-30株的丝氨酸蛋白酶基因(Spe)和溶血素基因(Hly),将基因Spe和Hly通过柔性片段进行融合,并将融合片段插入pET32a的多克隆位点,构建成重组融合表达载体pET32a-Spe-Hly。将重组载体转化大肠杆菌BL21(DE3),经异丙醛-β-D-硫代半乳糖苷(IPTG)诱导表达,获得融合蛋白Spe-Hly。表达产物经SDS-PAGE检测,显示与预期大小约130kD相吻合的融合蛋白带。纯化融合蛋白并对鲫鱼进行免疫攻毒试验。结果表明,丝氨酸蛋白酶基因和溶血素基因融合表达载体构建成功,并成功获得了融合蛋白Spe-Hly,对鲫鱼的免疫保护率达81.4%。这为基因工程亚单位多价疫苗的开发提供基础。       

Genetically engineered phage harbouring the lethal catabolite gene activator protein gene with an inducer-independent promoter for biocontrol of Escherichia coli

Complications of chemotherapy, such as appearance of multidrug resistance, have persuaded researchers to consider phage therapy as a new method to combat bacterial infections. In vitro experiments were performed to assess the therapeutic value of genetically modified phages for controlling gastrointestinal Escherichia coli O157:H7 cells in Luria–Bertani (LB) media and contaminated cow milk. We constructed a modified nonreplicating M13-derived phage expressing a lethal catabolite gene activator protein (CAP) that is a Glu181Gln mutant of CAP. The modified phagemid was propagated in the lethal CAP-resistant strain XA3DII. Time–kill assay experiments showed a considerable reduction in the number of surviving bacteria in both LB media and contaminated cow milk. Our further study using other test strains demonstrated that the host range of lethal phage is limited to E. coli strains that produce pili. This study provides a possible strategy for the exploitation of genetically engineered nonlytic phages as bactericidal agents by minimizing the risk of release of progeny phages and endotoxins into the environment. The phage was engineered to remain lethal to its bacterial target, but incapable of replicating therein. Furthermore, the addition of an inducer to express the lethal protein is not required.     

Preservation of Haemophilus influenzae and Haemophilus parainfluenzae at -70 degrees C.

We have studied the viability of Haemophilus spp. preserved for 5 to 12 months at -70 degrees C. The following media were used: Laboratoire de Santé Publique du Québec (LSPQ) preservation medium, trypticase soy broth with 10 degrees C (vol/vol) glycerol and 40 degrees C (vol/vol) horse serum (TSBG), and Levinthal's broth (LB) medium. Three clinical isolates of both H. influenzae and H. parainfluenzae were used. After 5 months no differences in viability were observed between strains preserved in TSBG and strains preserved in LB, but a significant loss of viability was observed in strains preserved in LSPQ medium. No significant changes in antimicrobial susceptibility were observed after 5-month storage in any medium. After 12 months, TSBG appeared to be the most suitable cryopreservation medium for the six strains tested. We conclude that TSBG represents a good medium for the maintenance of Haemophilus spp. at -70 degrees C for up to 1 year.     

Genetic engineering of Serratia marcescens with bacterial hemoglobin gene: effects on growth, oxygen utilization, and cell size

The bacterial hemoglobin from Vitreoscilla has been shown to increase growth yield and yield of genetically engineered product in Escherichia coli. To test the generality of this phenomenon, the approximately 560-bp bacterial (Vitreoscilla) hemoglobin gene (vgb) (including the native promoter), cloned into the vector pUC8 in two constructs containing about 1650 and 850 bp, respectively, of Vitreoscilla DNA downstream of vgb, was transformed into Serratia marcescens. After several transfers of the transformants on selective media, both plasmids became stable in this host and the resulting strains produced hemoglobin. Both transformants were compared, regarding growth in liquid Luria-Bertani (LB) medium, with untransformed S. marcescens and S. marcescens transformed with pUC8. The vgb-bearing strains had about 5 times lower maximum viable cell numbers than the strains without hemoglobin, but the former also had late log or early stationary phase cells that were 5-10 times larger than those of the latter. Further, on a dry cell mass basis the presence of vgb inhibited cell growth in liquid media. In contrast, growth of the vgb-bearing strains on LB plates based on cell mass (determined from colony size) was markedly enhanced compared with that of the pUC8 transformant. Respiration of the vgb-bearing strains was lower than that of the strains without vgb on a cell mass basis. These results show that the presence of vgb can have idiosyncratic effects and is not always an aid to cell growth so that its use for genetic engineering must be tested on a case by case basis.     

Genetic and physiological relationships between L-asparaginase I and asparaginase II in Saccharomyces cerevisiae.

The cistron that codes for L-asparaginase I in Saccharomyces cerevisiae (aspl) is not genetically linked to either of the cistrons coding for expression of asparaginase II (asp2 and asp3). Cells containing different combinations of theses enzymes grow at different rates in media in which L-asparagine or D-asparagine is the only source of nitrogen for cell replication. Cells lacking L-asparaginase I but possessing asparaginase II grow more rapidly in medium containing D-asparagine as a nitrogen source than cells containing both enzymes, even though D-asparagine is not a substrate of L-asparaginase I. These results indicate that L-asparaginase I and asparaginase II interact in some way to regulate the utilization of asparagine as a nitrogen source for cell growth.